Vesper Biotechnologies ApS
🇩🇰Denmark
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Vesper Biotechnologies ApS
- Target Recruit Count
- 78
- Registration Number
- NCT06226064
- Locations
- 🇳🇱
Center for Human Drug Research, Leiden, Netherlands
News
No news found